3 August 2005
Bear Stalking Biotech Sector
The biotech sector saw a significant run-up last month, but for at least one analyst, questions remain about what the second half holds.
Biotech Blog
The biotech sector saw a significant run-up last month, but for at least one analyst, questions remain about what the second half holds.
Yali Friedman lives in Washington, DC and is author of Building Biotechnology. He is also founder of DrugPatentWatch.com, and has a long history in biotechnology media. read more…
